跳至主要内容
临床试验/EUCTR2017-003687-12-SE
EUCTR2017-003687-12-SE进行中(未招募)1 期

Infusion rate and volumekinetics for hyperoncotic albumin in healthy subjects (RAV), -A phase IV, randomized, open-labeled, cross-over study - RAV

Region Ostergotland0 个研究点目标入组 12 人开始时间: 2017年9月22日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Healthy volunteers
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 12
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.> 60 år
  • 2.Anamsticaly known decreased kidney function
  • 3.Hypotensive problems, such as a feeling of dizzyness when rizing up to quickly.
  • 4.Hypertension (systolic blood pressure >150 and diastolic blood pressure > 95)
  • 5.Allergic reaction to albumin infusion.
  • 6.Taking part in a clinicak trial within 30 Days previously.
  • 7.Pregnancy, which is tested with Urin-hcg.
  • 8.Dementia or problems to understand instructions.

研究者

相似试验